Table 1.
Demographic characteristics of MDR-TB cases in Guizhou Province, 2014–2020 (n, %)
| Variables | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | Total |
|---|---|---|---|---|---|---|---|---|
| Total | 145 | 165 | 186 | 225 | 240 | 269 | 436 | 1666 |
| Percentage change (%) | – | 13.8 | 12.7 | 21.0 | 6.7 | 12.1 | 62.1 | – |
| Gender | ||||||||
| Male | 101 (69.7) | 125 (75.8) | 130 (69.9) | 142 (63.1) | 173 (72.1) | 177 (65.8) | 311 (71.3) | 1159 (69.6) |
| Female | 44 (30.3) | 40 (24.2) | 56 (30.1) | 83 (36.9) | 67 (27.9) | 92 (34.2) | 125 (28.7) | 507 (30.4) |
| Sex ratio | 2.3 | 3.1 | 2.3 | 1.7 | 2.6 | 1.9 | 2.5 | 2.3 |
| Age | ||||||||
| < 25 | 24 (16.6) | 28 (17.0) | 35 (18.8) | 50 (22.2) | 43 (17.9) | 32 (11.9) | 68 (15.6) | 280 (16.8) |
| 25–65 | 114 (78.6) | 125 (75.8) | 141 (75.8) | 159 (70.7) | 168 (70.0) | 213 (79.2) | 303 (69.5) | 1223 (73.4) |
| ≥ 65 | 7 (4.8) | 12 (7.3) | 10 (5.4) | 16 (7.1) | 29 (12.1) | 24 (8.9) | 65 (14.9) | 163 (9.8) |
| Ethnic group | ||||||||
| Han | 127 (87.6) | 141 (85.5) | 167 (89.8) | 200 (88.9) | 185 (77.1) | 212 (78.8) | 342 (78.4) | 1374 (82.5) |
| Others | 18 (12.4) | 24 (14.5) | 19 (10.2) | 25 (11.1) | 55 (22.9) | 57 (21.2) | 94 (21.6) | 292 (17.5) |
| Occupation | ||||||||
| Student | 6 (4.1) | 1 (0.6) | 1 (0.5) | 10 (4.4) | 15 (6.3) | 4 (1.5) | 20 (4.6) | 57 (3.4) |
| Government worker | 16 (11.0) | 4 (2.4) | 4 (2.2) | 2 (0.9) | 15 (6.3) | 15 (5.6) | 12 (2.8) | 68 (4.1) |
| Farmer | 68 (46.9) | 92 (55.8) | 111 (59.7) | 104 (46.2) | 104 (43.3) | 86 (32.0) | 161 (36.9) | 726 (43.6) |
| Migrant worker | 13 (9.0) | 8 (4.8) | 13 (7.0) | 51 (22.7) | 72 (30.0) | 154 (57.2) | 229 (52.5) | 540 (32.4) |
| Others (unemployed) | 42 (29.0) | 60 (36.4) | 57 (30.6) | 58 (25.8) | 34 (14.2) | 10 (3.7) | 14 (3.2) | 275 (16.5) |
| Anti-TB drug history | ||||||||
| Never use | 0 (0.0) | 0 (0.0) | 0 (0.0) | 16 (7.1) | 21 (8.8) | 15 (5.6) | 28 (6.4) | 80 (4.8) |
| Only 1st-line drugs | 114 (78.6) | 162 (98.2) | 174 (93.5) | 193 (85.8) | 187 (77.9) | 235 (87.4) | 397 (91.1) | 1462 (87.8) |
| 1st- and 2nd-line drugs | 31 (21.4) | 3 (1.8) | 12 (6.5) | 16 (7.1) | 32 (13.3) | 19 (7.1) | 11 (2.5) | 124 (7.4) |
MDR-TB multidrug-resistant tuberculosis, anti-TB anti-tuberculosis